Healthcare
PetMed Express, Inc.(PETS)
Live Price
Offline$1.75
-2.78% today
1Y Change
-44.79%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $50.00M
- Revenue Growth
- -17.2%
- EPS Growth
- +18.9%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PetMed Express, Inc. (PETS) is a Healthcare stock with a market cap of $50.00M and listed on NASDAQ. The stock last traded around $1.75 and down 44.8% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -17.2%, EPS growth of +18.9%, a dividend yield of 0.0%. What stands out right now is revenue -17.2%, EPS +18.9%, free cash flow -103.6% with operating margin -17.4% and ROIC -94.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PETS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-17.2% vs +7.6% peer median
Operating Margin
Below sector median
-17.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -17.2% and EPS is at +18.9%, with operating margin around -17.4%.
The next real check-in already has a date
The next earnings event is scheduled for Oct 13, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.9% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | -1.8% | -0.4% | -24.3% |
2026 Feb 5, 2026 | -733.3% | -3.4% | -1.7% | -12.4% |
2025 Dec 19, 2025 | -1600.0% | -2.8% | -3.6% | -6.1% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PETS
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PETS Max Drawdown
-59.80%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PETS and SPY.
Company Overview
PetMed Express, Inc.
NASDAQ Global Select
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
- Leadership
- Leslie C. G. Campbell
- IPO Date
- Apr 26, 1999
- Employees
- 287
- Street Address
- 420 South Congress Avenue
- Mailing
- Delray Beach, FL, 33445
- Region
- Delray Beach, FL, US
- Reporting Currency
- USD
- Investor Line
- 561 526 4444
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.3
- Price/Book
- 1.5
Growth
- Revenue
- -17.2%
- EPS
- +18.9%
- Free Cash Flow
- -103.6%
Profitability
- Gross Margin
- 29.0%
- Operating Margin
- -17.4%
- Net Margin
- -35.5%
- ROE
- -122.1%
- ROIC
- -94.2%
Balance Sheet
- Debt/Equity
- 0.02
- Current Ratio
- 0.89
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.